This pharmaphorum podcast explores how AI is transforming drug development and commercialization, with Norstella Chief Product Officer Kris Kaneta discussing the growing role of clinical AI powered by robust patient-level data. Kaneta explains how AI can move beyond administrative efficiency to deliver real strategic recommendations for clinical trials, commercialization and decision-making across the product lifecycle. The conversation also highlights why high-quality, connected patient-level data is becoming pharma’s most valuable competitive asset in the AI era, while addressing the key challenges limiting broader AI adoption and effectiveness in clinical research today.
